Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.610

-0.090 (-3.33%)

At close: Jul 19, 2024, 4:00 PM

2.600

-0.010 (-0.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Nautilus Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	30.4	28.9	25.95	21.15	3.31	1.62
Research & Development	49.3	47.25	37.67	29.35	12.43	8.49
Operating Expenses	79.7	76.15	63.62	50.5	15.74	10.11
Operating Income	-79.7	-76.15	-63.62	-50.5	-15.74	-10.11
Other Expense / Income	-12.26	-12.48	-5.69	-0.18	-0.13	-0.49
Pretax Income	-67.44	-63.68	-57.92	-50.32	-15.62	-9.62
Net Income	-67.44	-63.68	-57.92	-50.32	-15.62	-9.62
Shares Outstanding (Basic)	125	125	125	84	29	6
Shares Outstanding (Diluted)	125	125	125	84	29	6
Shares Change	0.44%	0.26%	47.51%	190.36%	379.48%	-
EPS (Basic)	-0.55	-0.51	-0.46	-0.60	-0.54	-1.59
EPS (Diluted)	-0.55	-0.51	-0.46	-0.60	-0.54	-1.59
Free Cash Flow	-57.85	-54.15	-48.13	-41.51	-14.92	-10.59
Free Cash Flow Per Share	-0.46	-0.43	-0.39	-0.49	-0.51	-1.75
EBITDA	-61.32	-57.97	-54.51	-47.47	-13.27	-9.07
Depreciation & Amortization	6.13	5.71	3.42	2.84	2.35	0.55
EBIT	-67.44	-63.68	-57.92	-50.32	-15.62	-9.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).